BENRALIZUMAB for Severe asthma with fungal sensitisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where BENRALIZUMAB was used for Severe asthma with fungal sensitisation.
Most Reported Side Effects for BENRALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 2,457 | 15.6% | 39 | 932 |
| Dyspnoea | 1,604 | 10.2% | 16 | 470 |
| Death | 1,336 | 8.5% | 1,333 | 40 |
| Drug ineffective | 1,266 | 8.0% | 18 | 431 |
| Cough | 793 | 5.0% | 2 | 168 |
| Headache | 788 | 5.0% | 3 | 123 |
| Product dose omission issue | 713 | 4.5% | 12 | 169 |
| Pneumonia | 710 | 4.5% | 38 | 403 |
| Wheezing | 619 | 3.9% | 0 | 154 |
| Malaise | 514 | 3.3% | 7 | 143 |
| Fatigue | 495 | 3.2% | 3 | 96 |
| Inappropriate schedule of product administration | 456 | 2.9% | 9 | 141 |
| Pyrexia | 455 | 2.9% | 4 | 144 |
| Arthralgia | 437 | 2.8% | 0 | 51 |
| Rash | 435 | 2.8% | 2 | 52 |
Other Indications for BENRALIZUMAB
Asthma (9,988)
Product used for unknown indication (311)
Chronic obstructive pulmonary disease (131)
Eosinophil count increased (60)
Eosinophilic granulomatosis with polyangiitis (56)
Eosinophilia (27)
Dyspnoea (24)
Hypereosinophilic syndrome (23)
Illness (23)
Nasal polyps (22)